Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$479M |
| 2 |
Meta Platforms (Facebook)
META
|
+$465M |
| 3 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$445M |
| 4 |
Kenvue
KVUE
|
+$434M |
| 5 |
Micron Technology
MU
|
+$431M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$3.24B |
| 2 |
Apple
AAPL
|
+$1.9B |
| 3 |
Microsoft
MSFT
|
+$1.56B |
| 4 |
PepsiCo
PEP
|
+$1.34B |
| 5 |
JPMorgan Chase
JPM
|
+$1.34B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.7% |
| 2 | Financials | 7.47% |
| 3 | Consumer Discretionary | 6.7% |
| 4 | Communication Services | 6.02% |
| 5 | Healthcare | 4.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3326
Timberland Bancorp
TSBK
$361M
| $1.1M | ﹤0.01% |
30,791
-175
| -0.6% | -$5.91K |
|
3327
Nordic American Tanker
NAT
$1.4B
| $1.1M | ﹤0.01% |
319,820
+31,005
| +11% | +$110K |
|
3328
PUT
Kinder Morgan
KMI
$71.4B
| $1.1M | ﹤0.01% |
40,000
| – | – |
|
3329
Liquidity Services
LQDT
$1.35B
| $1.1M | ﹤0.01% |
36,262
+2,962
| +9% | +$79.6K |
|
3330
Great Southern Bancorp
GSBC
$888M
| $1.09M | ﹤0.01% |
17,739
+5,124
| +41% | +$308K |
|
|
KMTS
3331
Kestra Medical Technologies
KMTS
$1.63B
| $1.09M | ﹤0.01% |
41,170
+22,507
| +121% | +$580K |
|
3332
Sweetgreen
SG
$721M
| $1.09M | ﹤0.01% |
161,412
-454,621
| -74% | -$3.12M |
|
3333
CALL
Energy Fuels
UUUU
$3.64B
| $1.09M | ﹤0.01% |
75,000
| – | – |
|
|
RWT
3334
Redwood Trust
RWT
$599M
| $1.09M | ﹤0.01% |
197,035
+8,115
| +4% | +$44.6K |
|
3335
PUT
Stellantis
STLA
$20.2B
| $1.09M | ﹤0.01% |
100,000
-1,000,000
| -91% | -$10.8M |
|
|
NPB
3336
Northpointe Bancshares
NPB
$603M
| $1.09M | ﹤0.01% |
64,780
+46,750
| +259% | +$791K |
|
3337
PUT
YPF Sociedad Anonima American Depositary Shares (Each representing ten (10) Class D shares of Capital Stock)
YPF
$19.4B
| $1.08M | ﹤0.01% |
30,000
-30,000
| -50% | -$995K |
|
3338
Corcept Therapeutics
CORT
$11.9B
| $1.08M | ﹤0.01% |
31,163
+18,182
| +140% | +$1.43M |
|
|
YSG
3339
Yatsen Holding
YSG
$319M
| $1.08M | ﹤0.01% |
277,877
+115,057
| +71% | +$731K |
|
|
HPP
3340
Hudson Pacific Properties
HPP
$787M
| $1.08M | ﹤0.01% |
99,690
+24,853
| +33% | +$369K |
|
3341
World Acceptance Corp
WRLD
$875M
| $1.08M | ﹤0.01% |
7,677
+822
| +12% | +$124K |
|
3342
Enliven Therapeutics
ELVN
$4.25B
| $1.08M | ﹤0.01% |
69,875
-814
| -1% | -$16.2K |
|
|
VTYX
3343
DELISTED
Ventyx Biosciences
VTYX
| $1.07M | ﹤0.01% |
118,702
+116,876
| +6,401% | +$873K |
|
|
ONTF
3344
DELISTED
ON24
ONTF
| $1.07M | ﹤0.01% |
134,266
-15,055
| -10% | -$85.3K |
|
|
FSUN
3345
FirstSun Capital Bancorp
FSUN
$2.02B
| $1.07M | ﹤0.01% |
28,392
+9,275
| +49% | +$338K |
|
3346
Invesco Mortgage Capital
IVR
$805M
| $1.07M | ﹤0.01% |
126,981
+31,165
| +33% | +$244K |
|
3347
Insteel Industries
IIIN
$634M
| $1.07M | ﹤0.01% |
33,697
+5,324
| +19% | +$174K |
|
3348
PUT
Invesco
IVZ
$14.3B
| $1.07M | ﹤0.01% |
+40,600
| New | +$992K |
|
|
SFIX
3349
Stitch Fix
SFIX
$487M
| $1.07M | ﹤0.01% |
203,140
-185,342
| -48% | -$846K |
|
3350
ATN International
ATNI
$491M
| $1.06M | ﹤0.01% |
46,678
+7,832
| +20% | +$145K |
|
Similar funds
Barclays's Q4 2025 Portfolio in Review
As of Q4 2025, Barclays held 5,847 positions worth $417B, down 9.7% from $461B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Barclays withdrew a net $49.1B in Q4 2025, closing 641 positions and reducing 1,715 holdings. Its most notable exit was Verona Pharma, an estimated $149M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Barclays opened a new position in The Magnum Ice Cream Company N.V. worth $156M.
- Barclays's largest Q4 2025 buy was The Magnum Ice Cream Company N.V.: 9,862,859 shares worth $156M.
- Barclays added most to Gilead Sciences in Q4 2025, an estimated $479M increase.
- Barclays's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $3.24B.
- Barclays fully exited Verona Pharma in Q4 2025, selling an estimated $149M.
- Barclays's ten largest holdings make up 35% of its $417B portfolio in Q4 2025.
- Barclays opened 403 new positions and closed 641 in Q4 2025.
- Barclays's portfolio value fell 9.7% quarter-over-quarter to $417B.
Based on Barclays's 13F filing for Q4 2025, filed 13 Feb 2026.